Telix Pharmaceuticals (TLPPF) Assets Average (2024 - 2026)

Telix Pharmaceuticals (TLPPF) has reported Assets Average for 3 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets Average changed N/A year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $1.3 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 72.82% from the prior year.
• Assets Average was $1.3 billion for Q2 2026 at Telix Pharmaceuticals, up from $1.1 billion in the prior quarter.
• Over five years, Assets Average peaked at $1.3 billion in Q2 2026 and troughed at $628.0 million in Q4 2024.
• A 3-year average of $989.6 million and a median of $1.1 billion in 2025 frame the typical range for Assets Average.
• The widest YoY moves for Assets Average: up 71.64% in 2025, down 71.64% in 2025.
• Over 3 years, Assets Average stood at $628.0 million in 2024, then soared by 71.64% to $1.1 billion in 2025, then advanced by 17.17% to $1.3 billion in 2026.
• The last three Assets Average figures came in at $1.3 billion (Q2 2026), $1.1 billion (Q4 2025), and $628.0 million (Q4 2024), per Business Quant data.